Skip to content
Synovo
Toggle menu
  • Home
  • Services
    • Summary Services
    • Disease Models
    • Chemistry Services
    • Histology
  • Innovation
  • TeamScience
  • Career
  • News
  • Contact

Orphan designation for treatment of CF

By synovo20. February 20148. January 2018Orphan Drugs

Our compound SYD0073 has been granted orphan designation (EU/3/14/1239) by the European Medicines Agency (EMA) for the treatment of cystic fibrosis.

Post navigation

Orphan designation for pancreatic cancer

Synovo GmbH
Paul-Ehrlich-Str. 15
72070 Tübingen
Germany

Synovo GmbH
Paul-Ehrlich-Str. 15
D-72076, Tübingen
Germany

T +49 (0) 7071 964325
F +49 (0) 7071 964326
contact@synovo.com

NOVIRUSES2BRAIN

Legal Notice

Datenschutzerklärung
© 2023 Synovo. Proudly powered by Sydney